Novel Coagulation Factor VIII Gene Therapy in a Mouse Model of Hemophilia A by Lipid-Coated Fe(3)O(4) Nanoparticles

Hemophilia A is a bleeding disease caused by loss of coagulation factor VIII (FVIII) function. Although prophylactic FVIII infusion prevents abnormal bleeding, disability and joint damage in hemophilia patients are common. The cost of treatment is among the highest for a single disease, and the adve...

Descripción completa

Detalles Bibliográficos
Autores principales: Kao, Yung-Tsung, Chen, Yen-Ting, Fan, Hueng-Chuen, Tsai, Tung-Chou, Cheng, Shin-Nan, Lai, Ping-Shan, Chen, Jen-Kun, Chen, Chuan-Mu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464966/
https://www.ncbi.nlm.nih.gov/pubmed/34572302
http://dx.doi.org/10.3390/biomedicines9091116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464966/
https://www.ncbi.nlm.nih.gov/pubmed/34572302
http://dx.doi.org/10.3390/biomedicines9091116

Ejemplares similares